发明名称 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation
摘要 <p>The present invention relates to the modulation of glucocorticoid metabolism. In particular, the invention relates to the modulation of the functional activity of the glucocorticoid receptor by 5α reduced metabolic breakdown products of glucocorticoids. The invention relates to the treatment of inflammatory conditions in a patient.</p>
申请公布号 EP1808176(A3) 申请公布日期 2007.12.26
申请号 EP20070004317 申请日期 2003.06.16
申请人 THE UNIVERSITY OF EDINBURGH 发明人 WALKER, BRAIN ROBERT;ANDREW, RUTH
分类号 A61K31/56;A61K45/00;A61K31/00;A61K31/405;A61K31/435;A61K31/473;A61K31/573;A61K31/59;A61P1/16;A61P3/02;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P17/00;A61P17/02;A61P17/10;A61P17/14;A61P25/00;A61P25/28;A61P29/00;A61P43/00 主分类号 A61K31/56
代理机构 代理人
主权项
地址